- Global Pharma News & Resources

Press Releases - 2020-07-28

Date Title Company
28-Jul-2020 Nektar to Announce Financial Results for the Second Quarter 2020 on Thursday, August 6, 2020, After Close of U.S.-Based Financial Markets Nektar Therapeutics
28-Jul-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
28-Jul-2020 VantAI and TARA Biosystems partner to discover new medicines TARA BIOSYSTEMS AND VANTAI
28-Jul-2020 Valeo Pharma to Present at Wall Street Reporter's Livestream Conference on July 29, 2020 Valeo Pharma inc.
28-Jul-2020 APhA Expresses Disappointment Over Absence of Temporary Provider Status Language in HEALS Act American Pharmacists Association
28-Jul-2020 Former Yahoo! Chairman, Wall Street Titan Roy J. Bostock Joins GID BIO as Chairman GID BIO
28-Jul-2020 Lilly's P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimer's Disease in Data Published in JAMA Eli Lilly and Company
28-Jul-2020 Chair Appointed To Lead NHS Drive To Reduce Health Inequalities NHS England
28-Jul-2020 Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd Swedish Biomimetics 3000®
28-Jul-2020 Chiesi publishes its annual report: Group generates almost €2 billion turnover and obtains B Corp certification in 2019 Chiesi Group
28-Jul-2020 Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® Acacia Pharma Group plc
28-Jul-2020 Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections Destiny Pharma plc
28-Jul-2020 Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV Fund+
28-Jul-2020 Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications Oculis
28-Jul-2020 CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture CPI
28-Jul-2020 European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis Celltrion Healthcare
28-Jul-2020 Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China Chi-Med
28-Jul-2020 Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China Chi-Med
28-Jul-2020 Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease AstraZeneca
28-Jul-2020 Awarded Contract from Codagenix Inc. New York USA for COVID-19 Vaccine Trial Open Orphan plc